These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8200948)

  • 1. Circulating growth hormone isoforms in girls with Turner's syndrome.
    Blethen SL; Albertsson-Wikland K; Faklis EJ; Chasalow FI
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1439-43. PubMed ID: 8200948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group.
    Veldhuis JD; Sotos JF; Sherman BM
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone secretion in pubertal age patients with Turner's syndrome.
    Lanes R; Brito S; Suniaga M; Moncada G; Borges M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):770-2. PubMed ID: 2394779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.
    Ishikawa M; Yokoya S; Tachibana K; Hasegawa Y; Yasuda T; Tokuhiro E; Hashimoto Y; Tanaka T
    J Clin Endocrinol Metab; 1999 Jan; 84(1):98-104. PubMed ID: 9920068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The GHRH test in Turner's syndrome].
    Saggese G; Cesaretti G; Cioni C
    Minerva Pediatr; 1991 Jun; 43(6):437-43. PubMed ID: 1886528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?
    Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P; Eggermont E
    J Clin Endocrinol Metab; 1990 May; 70(5):1445-51. PubMed ID: 2186059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile growth hormone release in Turner's syndrome and short normal children.
    Ghizzoni L; Lamborghini A; Ziveri M; Volta C; Panza C; Balestrazzi P; Bernasconi S
    Acta Endocrinol (Copenh); 1990 Sep; 123(3):291-7. PubMed ID: 2239077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis.
    Wit JM; Massarano AA; Kamp GA; Hindmarsh PC; van Es A; Brook CG; Preece MA; Matthews DR
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):7-12. PubMed ID: 1519426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four hour plasma GH, FSH and LH profiles in patients with Turner's syndrome.
    Villadolid MC; Takano K; Hizuka N; Asakawa K; Sukegawa I; Horikawa R; Shizume K
    Endocrinol Jpn; 1988 Feb; 35(1):71-81. PubMed ID: 3135180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
    Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
    Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure.
    Boguszewski CL; Jansson C; Boguszewski MC; Rosberg S; Carlsson B; Albertsson-Wikland K; Carlsson LM
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2944-9. PubMed ID: 9284724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
    Reiter JC; Craen M; Van Vliet G
    Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
    Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
    Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone response to growth hormone releasing hormone 1-40 in Turner's syndrome.
    Cappa M; Loche S; Borrelli P; Corda R; Marini R; Porcedda C; Pintor C
    Horm Res; 1987; 27(1):1-6. PubMed ID: 3114115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation.
    Zadik Z; Landau H; Chen M; Altman Y; Lieberman E
    J Clin Endocrinol Metab; 1992 Aug; 75(2):412-6. PubMed ID: 1386373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.
    Hanew K; Tanaka A; Utsumi A
    J Endocrinol Invest; 1998 Feb; 21(2):72-7. PubMed ID: 9585379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.